Immatics N.V. (IMTX) vs Replimune Group, Inc. (REPL)
Immatics N.V. and Replimune Group, Inc. are both Biotechnology companies. Immatics N.V. and Replimune Group, Inc. are of similar size ($1.3B and $1.2B). Replimune Group, Inc. has the higher net margin (0.00% vs −489.4%) and the lower return on invested capital (−1,154.7% vs −84.8%). Across the 14 metrics below, Immatics N.V. leads on 9 and Replimune Group, Inc. on 5.
Valuation
Profitability
| Metric | IMTX | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (536.26%) | 0.00% | 0.00% |
| Net margin | (489.35%) | 0.00% | 0.00% |
| Free cash flow margin | (488.01%) | 0.00% | 0.00% |
| Return on equity | (48.53%) | (134.29%) | (57.72%) |
| Return on assets | (39.83%) | (82.28%) | (49.22%) |
| Return on invested capital | (84.83%) | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack